Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease

Abstract

The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 15, 2014
  • Application: Aug 9, 2004
    US US 91521404 A
  • Priority: Aug 9, 2004
    US US 91521404 A
  • Priority: Oct 31, 2003
    US US 69951703 A
  • Priority: Oct 31, 2003
    US US 69809903 A
  • Priority: Nov 1, 2002
    US US 42301202 P

Download Citation


Sign in to the Lens

Feedback